Recent Healthcare Dealmaking Symposium Posts
[Posted on March 10, 2009 at 3:35 PM]
|
Despite uncertainty around the administration's healthcare reform plans, dealmakers at The Deal LLC's Healthcare Dealmaking Symposium see opportunities in pharmaceutical and biotech deals.
Continue reading
|
|
[Posted on March 10, 2009 at 3:22 PM]
|
At The Deal LLC's Healthcare Dealmaking Symposium, a Tuesday morning panel discussed the possibility of growing antitrust scrutiny by the Obama administration for healthcare deals.
Continue reading
|
|
[Posted on March 10, 2009 at 2:07 PM]
|
Speaking at The Deal LLC's Healthcare Dealmaking Symposium, the Mintz Levin attorney said Congress needs some education on existing programs before reforming the system.
Continue reading
|
|
[Posted on March 10, 2009 at 1:58 PM]
|
At The Deal LLC's Healthcare Dealmaking Symposium, a Tuesday morning panel discussed the necessary changes President Obama must undertake to successfully reform healthcare in the U.S.
Continue reading
|
|
[Posted on March 10, 2009 at 1:42 PM]
|
Dr. Albert Waxman, the CEO of venture capital firm Psilos Group, spoke at The Deal's Healthcare Dealmaking Symposium about ways to control healthcare costs.
Continue reading
|
|
[Posted on March 10, 2009 at 1:16 PM]
|
Sam Isaly, the founder and managing partner at private equity firm OrbiMed Advisor, was the subject of the Tuesday morning keynote interview at The Deal LLC's Healthcare Dealmaking Symposium.
Continue reading
|
|
[Posted on March 10, 2009 at 12:47 PM]
|
At The Deal LLC's Healthcare Dealmaking Symposium, attorney Keith Pagnani commented on how the dealmaking landscape for biotechs is changing.
Continue reading
|
|
[Posted on March 10, 2009 at 12:26 PM]
|
At The Deal LLC's Healthcare Dealmaking Symposium Tuesday morning, a group of private equity professionals spoke about the M&A landscape in the sector.
Continue reading
|
|
[Posted on March 10, 2009 at 12:18 PM]
|
Richard H. Stowe, general partner at Health Enterprise Partners, said the recession is taking its toll on healthcare and pharma mergers despite a few recent megadeals.
Continue reading
|
|
[Posted on March 10, 2009 at 12:13 PM]
|
At The Deal LLC's Healthcare Dealmaking Symposium, Apax Partner's Buddy Gumina commented on the possible opportunities of the Obama administration's plans for healthcare reform.
Continue reading
|
|
[Posted on April 10, 2008 at 12:40 PM]
Proskauer Rose LLP partner Richard J. Zall spoke at The Deal's Healthcare Dealmaking Conference on potential unknown liabilities involved in healthcare M&A. - George White...
Continue reading
|
|
[Posted on April 10, 2008 at 12:26 PM]
Fiona Schaeffer, a partner at Weil, Gotshal & Manges, spoke at The Deal's Healthcare Dealmaking Conference on increasing difficulties surrounding regulatory approvals for healthcare M&A. "I think these cases raise...
Continue reading
|
|
[Posted on April 7, 2008 at 5:40 PM]
David P. Wales Jr., deputy director of the Federal Trade Commission's Bureau of Competition, discussed how the FTC evaluates hospital mergers and pharmaceutical mergers and its ongoing investigations at The...
Continue reading
|
|
Browse past entries in the Healthcare Dealmaking Symposium category by date
Browse other archives
« Distressed Investing |
Home
| IBF VC conference 2007 »
Categories
Blog roll
Archives
|
